Business Description
MediciNova Inc
NAICS : 325412
SIC : 2834
ISIN : US58468P2065
Description
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 209.31 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 14.3 | |||||
| 3-Year EPS without NRI Growth Rate | 18.1 | |||||
| 3-Year FCF Growth Rate | 14.7 | |||||
| 3-Year Book Growth Rate | -7.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -11.37 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -40.31 | |||||
| 12-1 Month Momentum % | -40.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.66 | |||||
| Quick Ratio | 16.66 | |||||
| Cash Ratio | 16.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 0.33 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -922.46 | |||||
| ROE % | -17.19 | |||||
| ROA % | -16.3 | |||||
| ROIC % | -77.76 | |||||
| ROC (Joel Greenblatt) % | -2167.33 | |||||
| ROCE % | -19.83 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 106 | |||||
| PB Ratio | 1.89 | |||||
| Price-to-Tangible-Book | 2.55 | |||||
| EV-to-EBIT | -5.29 | |||||
| EV-to-EBITDA | -5.3 | |||||
| EV-to-Revenue | 63.32 | |||||
| EV-to-FCF | -6.88 | |||||
| Price-to-Net-Current-Asset-Value | 2.6 | |||||
| Price-to-Net-Cash | 2.65 | |||||
| Earnings Yield (Greenblatt) % | -18.92 | |||||
| FCF Yield % | -8.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MediciNova Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.917 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 40.5 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.103071 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | -40.79 | ||
| 52-Week Range (€) | 2.672 - 10.5 | ||
| Shares Outstanding (Mil) | 48.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MediciNova Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MediciNova Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
MediciNova Inc Frequently Asked Questions
What is MediciNova Inc(FRA:RMN)'s stock price today?
The current price of FRA:RMN is €2.78. The 52 week high of FRA:RMN is €10.50 and 52 week low is €2.67.
When is next earnings date of MediciNova Inc(FRA:RMN)?
The next earnings date of MediciNova Inc(FRA:RMN) is 2025-02-13 Est..
Does MediciNova Inc(FRA:RMN) pay dividends? If so, how much?
MediciNova Inc(FRA:RMN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers